ICS + LABA inhaler
Fluticasone with formoterol
Brand names: Flutiform
Adult dose
Dose: 2 puffs BD; strengths 50/5, 125/5, 250/10 micrograms
Route: Inhaled
Frequency: BD
Clinical pearls
- Asthma not controlled on ICS alone
- Not licensed for COPD
Contraindications
- Hypersensitivity
Side effects
- Tremor
- Tachycardia
- Hypokalaemia
- Oral candidiasis
- Hoarseness
Interactions
- β-blockers
- QT-prolonging drugs
- Strong CYP3A4 inhibitors
Monitoring
- Asthma control
- Inhaler technique
Reference: BNF; BTS/SIGN; https://bnf.nice.org.uk/drugs/fluticasone-with-formoterol/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024